All articles by Praveen Duddu

  1. M&As this week: Cipher Pharmaceuticals, Sygnis AG

    Canada-based pharmaceutical company Cipher Pharmaceuticals Inc has reached an agreement to acquire Cardiome Pharma Corp for a non-dilutive consideration of C$25.5m…
    Read More…

    23 Mar
  2. Deals this week: TCR2 Therapeutics, DBV Technologies, Novartis

    US-based immuno-oncology company TCR2 Therapeutics Inc has completed a series B venture financing round co-led by 6 Dimensions Capital and Curative…
    Read More…

    23 Mar
  3. M&As this week: Biomx, Pace Analytical Services, Millendo Therapeutics

    Israel-based microbiome drug discovery company Biomx has announced the acquisition of biotechnology company Rondinx. The acquisition will expand BiomX’s therapeutic…
    Read More…

    22 Dec
  4. Deals this week: DiCE Molecules, Entrega, Ono Pharmaceutical

    US-based biotechnology company DiCE Molecules has signed an agreement to discover new small molecules against multiple targets using its technology…
    Read More…

    22 Dec
  5. Deals this week: Blue Oak Pharmaceuticals, Mustang Bio, iVeena Delivery Systems

    US-based therapeutics developer for brain disorders Blue Oak Pharmaceuticals Inc has collaborated with pre-clinical contract research and drug discovery services…
    Read More…

    8 Dec
  6. Deals this week: Zensun Sci & Tech Co Ltd, Onconova Therapeutics Inc

    Zensun Sci & Tech Co Ltd has secured $76.5m in funding from SDIC Venture Capital Management, China Venture Capital Co…
    Read More…

    24 Nov
  7. M&As this week: Cerecor Inc, Body and Mind Inc

    Cerecor Inc’s subsidiary ZPC Merger Corp has acquired Zylera Pharmaceuticals from TRx Pharmaceuticals LLC for $27m. Cerecor is a US-based…
    Read More…

    24 Nov
  8. Deals this week: Horama, Voyager Therapeutics, Fibrocell Science

    Horama SAS has raised €19m ($22m) in a series B funding round led by Fundplus, Pontifax Ltd, and IDInvest Partners….
    Read More…

    10 Nov
  9. M&As this week: Yifan Pharmaceutical, BioClinica

    Yifan Pharmaceutical plans to acquire Hong Kong-based pharmaceutical products distributor NovoTek Pharmaceuticals for CNY136m ($20.6m). The Chinese pharmaceutical company will complete…
    Read More…

    10 Nov
  10. Deals this week: Idera, Catalyst Biosciences, ADC Therapeutics

    Idera Pharmaceuticals Inc plans to raise $60m through an underwritten public offering of shares of its common stock. The US-based…
    Read More…

    27 Oct